Locus 107: SLC27A2 (15q21.2)
| Meta-analysis summary statistics for associations meeting genome-wide significance |
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs1365505 |
10-undecenoate (11:1n1) / X-11438 |
T/C |
6650 |
0.68 |
-0.025 (0.003) |
3.84·10-14 |
show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs1365505 |
| Chromosomal location | Chr15: 48,264,430 (15q21.2) |
| Gene (distance) | SLC27A2 (0) |
| Predicted causal gene | SLC27A2 |
| Gene/protein classification | - |
| Metabolite (Pathway) | 10-undecenoate (11:1n1) (Medium chain fatty acid; Lipid) X-11438 (Unknown) |
| Biochemical locus-metabolite relationship | SLC27A2 encodes a very-long-chain acyl-CoA synthetase which activates fatty acids by forming their coenzyme A derivatives [10198260]. Ratio interpretation: n/a. |
| eQTL associations | - |
| Medical information |
| Complex trait associations | - |
| Known metabolite associations | - |
| Inborn error of metabolism | - |
| Pharmacological information |
| ChEMBL ID | CHEMBL4326 |
| Drug information |
Compounds with activity in ChEMBL
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |

